These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate]. Feng YJ, Zhang XY. Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067 [Abstract] [Full Text] [Related]
3. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer]. Thurzó L. Zentralbl Gynakol; 1990 May; 112(17):1111-5. PubMed ID: 2148245 [Abstract] [Full Text] [Related]
4. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content. Metzger DA, Lessey BA, Soper JT, McCarty KS, Haney AF. Obstet Gynecol; 1991 Nov; 78(5 Pt 2):946-50. PubMed ID: 1833687 [Abstract] [Full Text] [Related]
5. [Adjuvant gestagen therapy in stage I endometrial cancer]. Lahousen M, Pickel H. Zentralbl Gynakol; 1988 Nov; 110(16):1013-7. PubMed ID: 2973195 [Abstract] [Full Text] [Related]
6. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy]. Vavra N, Salzer H, Sevelda P, Breitenecker G, Czerwenka K, Kucera H. Gynakol Rundsch; 1990 Nov; 30(3):133-43. PubMed ID: 2147161 [Abstract] [Full Text] [Related]
7. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy]. Thurzó L, Sas M, Falkay G. Orv Hetil; 1986 Oct 26; 127(43):2613-6. PubMed ID: 2947029 [No Abstract] [Full Text] [Related]
8. [Current status of drug treatment of endometrial carcinoma]. Schulz KD, Kaiser R. Gynakologe; 1983 Jun 26; 16(2):114-8. PubMed ID: 6193040 [No Abstract] [Full Text] [Related]
10. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer. Nomura Y, Tashiro H, Hisamatsu K, Shinozuka K. Anticancer Res; 1988 Jun 16; 8(4):647-51. PubMed ID: 2972248 [Abstract] [Full Text] [Related]
11. [Growth of endometrial cancer and hormone]. Kanoh H, Hosono T, Matsui Y, Okudaira Y. Gan To Kagaku Ryoho; 1989 Dec 16; 16(12):3696-703. PubMed ID: 2531993 [Abstract] [Full Text] [Related]
12. [Progestins in combined treatment of endometrial cancer]. Voznyĭ EK, Titova VA. Sov Med; 1990 Dec 16; (9):102-7. PubMed ID: 2148437 [No Abstract] [Full Text] [Related]
13. Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment. Lindahl B, Alm P, Fernö M, Norgren A. Anticancer Res; 1990 Dec 16; 10(3):725-30. PubMed ID: 2142394 [Abstract] [Full Text] [Related]
14. Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins. Holinka CF, Deligdisch L, Deppe G, Fleming H, Namit C, de la Pena MM, Gurpide E. Adv Exp Med Biol; 1981 Dec 16; 138():365-76. PubMed ID: 6211063 [No Abstract] [Full Text] [Related]
15. Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer. Fujimoto J, Fujita H, Hosoda S, Okada H. Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov 16; 41(11):1836-40. PubMed ID: 2531782 [Abstract] [Full Text] [Related]
16. [A case of marked effectiveness using medroxyprogesterone acetate (MPA) in lung metastases of cancer of the uterine body]. Takeda M, Kubo K, Fukushima M, Hirayama J, Sekiguchi M. Gan To Kagaku Ryoho; 1990 Oct 16; 17(10):2113-7. PubMed ID: 2145808 [Abstract] [Full Text] [Related]
17. [Clinovir treatment of adenocarcinoma of the uterus with lung metastases]. Stertmann WA, Hocke M, Röttger P. MMW Munch Med Wochenschr; 1983 Jul 22; 125(29-30):685-6. PubMed ID: 6225946 [No Abstract] [Full Text] [Related]
18. Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence. Montag TW, Manart FD. Gynecol Oncol; 1989 May 22; 33(2):255-60. PubMed ID: 2539319 [Abstract] [Full Text] [Related]